Date | Time | Place | Session / Title | Role |
April 27 | 5:00 PM - 6:10 PM | Presentation Theater 1, Level 1 | Valves | Panelist |
April 27 | 5:24 PM - 5:32 PM | Presentation Theater 1, Level 1 | Valves Failing Bioprosthetic Valves: Valve Fracture, Basilica, and Others |
Lecturer |
April 28 | 8:10 AM - 9:40 AM | Main Arena, Level 3 | Live Case Session I | Discussant |
April 28 | 2:00 PM - 3:06 PM | Presentation Theater 1, Level 1 | Antithrombotics | Moderator |
April 28 | 2:53 PM - 3:01 PM | Presentation Theater 1, Level 1 | Antithrombotics The Emerging Role of NOACs in the Management of Stable CAD and PAD |
Lecturer |
April 28 | 3:20 PM - 3:40 PM | Interview Lounge, Level 2 | Antithrombotics | Moderator |
April 29 | 9:30 AM - 9:38 AM | Presentation Theater 1, Level 1 | Spotlights of Major Clinical Studies with Expert Commentary A Journey of PCSK9 Inhibitors: From Genetics To Clinics |
Lecturer |
April 29 | 9:45 AM - 11:00 AM | Presentation Theater 1, Level 1 | 2019 New Data from AMC; Novel and More with Expert Commentary | Moderator |
April 29 | 10:23 AM - 10:30 AM | Presentation Theater 1, Level 1 | 2019 New Data from AMC; Novel and More with Expert Commentary Discussion: Association of Lp(a) and Recurrent Ischemic Event After PCI |
Discussant |
April 29 | 10:53 AM - 11:00 AM | Presentation Theater 1, Level 1 | 2019 New Data from AMC; Novel and More with Expert Commentary Discussion: DECISION-CTO Substudies and Cost-Effectiveness Analysis |
Discussant |
April 29 | 2:00 PM - 4:00 PM | Presentation Theater 1, Level 1 | Valves | Panelist |
April 29 | 3:07 PM - 3:15 PM | Presentation Theater 1, Level 1 | Valves QOL Outcomes of the COAPT Trial |
Lecturer |
April 29 | 4:30 PM - 4:50 PM | Interview Lounge, Level 2 | Valve | Interviewee |
April 30 | 8:35 AM - 10:20 AM | Structural Heart & Endovascular Theater, Level 1 | Live Case & Lecture Session I | Discussant |
April 30 | 12:45 PM - 1:45 PM | Presentation Theater 1, Level 1 | SAPIEN 3 TAVR | Panelist |